BCMA CAR-T induces complete and durable remission in plasmablastic lymphoma synchronous transformation of chronic lymphocytic leukemia: Case report and literature review
Feng S, Xiong Y, Liu W, Liu H, Sui W, Zheng P, Sun M, Hu K, Zhang Y. BCMA CAR-T induces complete and durable remission in plasmablastic lymphoma synchronous transformation of chronic lymphocytic leukemia: Case report and literature review. Critical Reviews In Oncology/Hematology 2024, 205: 104551. PMID: 39510436, DOI: 10.1016/j.critrevonc.2024.104551.Peer-Reviewed Original ResearchConceptsChronic lymphocytic leukemiaPlasmablastic lymphomaCAR-TLymphocytic leukemiaTransformation of chronic lymphocytic leukemiaCAR-T cell treatmentBruton tyrosine kinase inhibitorPatient's chronic lymphocytic leukemiaRight supraclavicular massNovel targeted agentsTyrosine kinase inhibitorsRichter transformationSupraclavicular massBrentuximab vedotinTargeted therapyTargeted agentsRare caseBone marrowCase reportTherapy choiceKinase inhibitorsInnovative therapiesCell treatmentTherapyBCMA
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply